ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 203 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $21,583,000 | +422.8% | 803,819 | +214.8% | 0.03% | +333.3% |
| Q4 2018 | $4,128,000 | -60.3% | 255,310 | -49.0% | 0.01% | 0.0% |
| Q3 2018 | $10,396,000 | +180.1% | 500,812 | +106.1% | 0.01% | +20.0% |
| Q2 2018 | $3,711,000 | -73.6% | 243,048 | -61.1% | 0.01% | -72.2% |
| Q1 2018 | $14,032,000 | -23.0% | 624,472 | +3.2% | 0.02% | -21.7% |
| Q4 2017 | $18,215,000 | -13.3% | 604,951 | +8.5% | 0.02% | -17.9% |
| Q3 2017 | $21,004,000 | +383.5% | 557,590 | +258.0% | 0.03% | +366.7% |
| Q2 2017 | $4,344,000 | +1.1% | 155,772 | +24.6% | 0.01% | 0.0% |
| Q1 2017 | $4,298,000 | +21.9% | 125,022 | +2.2% | 0.01% | 0.0% |
| Q4 2016 | $3,527,000 | +4.4% | 122,300 | +15.2% | 0.01% | 0.0% |
| Q3 2016 | $3,378,000 | -3.0% | 106,201 | -1.0% | 0.01% | 0.0% |
| Q2 2016 | $3,481,000 | -65.7% | 107,238 | -70.4% | 0.01% | -68.4% |
| Q1 2016 | $10,145,000 | -19.1% | 362,844 | +3.1% | 0.02% | -17.4% |
| Q4 2015 | $12,544,000 | +8.4% | 351,864 | +0.5% | 0.02% | 0.0% |
| Q3 2015 | $11,575,000 | -24.2% | 350,011 | -4.1% | 0.02% | -17.9% |
| Q2 2015 | $15,279,000 | +31.8% | 364,838 | +2.5% | 0.03% | +27.3% |
| Q1 2015 | $11,596,000 | +3.1% | 355,803 | +0.4% | 0.02% | 0.0% |
| Q4 2014 | $11,248,000 | +28.1% | 354,278 | -0.1% | 0.02% | +22.2% |
| Q3 2014 | $8,780,000 | +9.6% | 354,598 | 0.0% | 0.02% | +12.5% |
| Q2 2014 | $8,010,000 | -8.0% | 354,598 | -0.9% | 0.02% | -15.8% |
| Q1 2014 | $8,703,000 | +7.6% | 357,691 | +10.5% | 0.02% | +5.6% |
| Q4 2013 | $8,087,000 | – | 323,611 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |